Send to

Choose Destination
Eur J Clin Pharmacol. 1994;46(5):481-3.

Genetically determined sparteine oxidation polymorphism in a Polish population.


The genetic oxidation polymorphism was determined in 160 healthy Polish volunteers from the south-west of Poland (Wrocław region), using sparteine as a model drug. The results of a Polish population study revealed a bimodal distribution of the sparteine metabolic ratio and showed the existence of two oxidation phenotypes designated as extensive and poor metabolizers. The frequency of poor metabolizers in our study (8.8%) compares well with most results of poor oxidation metabolizers in Caucasian populations.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center